SGHT.US Sight Sciences Inc

Healthcare Health Care Equipment & Supplies USA Stocks
10.49 USD
Close of Nov 18, 2026
3.38 11.60
Market cap
USD 583M
P/E
-
P/B
11.98x
ROE
-65.8%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is SGHT.US undervalued?

Graham number

The Graham number of Sight Sciences Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Sight Sciences Inc fundamental analysis

No fundamental analysis for Sight Sciences Inc yet.

Sight Sciences Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Sight Sciences Inc

Sight Sciences, Inc., an ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases in the United States. The company operates in two segments, Surgical Glaucoma and Dry Eye. It offers OMNI, a surgical system family of products, such as OMNI Ergo for the catheterization and transluminal viscodilation of Schlemm's canal and cutting of the trabecular meshwork to reduce…

Full company profile